
Nutex Health rose 18.5% from $137.21 to $162.64, ahead of the S&P 500's +3.2%. Its worst day was Feb 4 (−19.0%), and its low came Mar 12 at $87.01.
Nov 24, 2025 – Nov 20, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Nutex Health shares rose 19.0%, while the S&P 500 rose 0.1%.
+19.0% · S&P 500 +0.1%
Story events cover the past 12 months · Times ET
Nutex Health shares fell 19.0%, while the S&P 500 fell 0.5%.
−19.0%, the year's worst day · S&P 500 −0.5%
EPS of $1.61 missed the $5.56 estimate on $151.7M revenue (est. $258.8M).
−14.3%, on 810K shares, the year's heaviest volume · S&P 500 −1.3%
EPS of $6.52 beat the $5.56 estimate on $216.5M revenue (est. $227.8M).
+17.1% · S&P 500 +0.3%
EPS of $9.38 beat the $5.03 estimate on $210.8M revenue (est. $216.0M).
+6.7% · S&P 500 +0.6%
Nutex Health closed at its highest level of the year, 64.0% above where the year started.
+3.9% · S&P 500 +0.7%
EPS of $5.71 beat the $5.54 estimate on $217.6M revenue (est. $215.2M).
−6.8% · S&P 500 +0.3%
Where it ended: a close of $162.64 on Nov 20, 2026. Up next: Q4 2026 earnings on Mar 4, 2027 (EPS est. $5.89, revenue est. $226.5M).
Nothing in the past 12 months.
All NUTX dividend historyReplay the year: the line draws itself and stops at each of the 7 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for NUTX and SPY from Benzinga historical bars. Not investment advice.